Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies
September 09, 2024 08:01 ET
|
Pasithea
Pasithea completes chronic toxicity studies for PAS-004, showing safety and potential for long-term use in NF1 and cancer treatment; Phase 1 trial ongoing
Pasithea Therapeutics to Present New Preclinical Data Showing PAS-004 Strongly Inhibits NRAS Cancer Cell Lines and Demonstrates Superior Activity in Xenograft Studies at 2024 ASCO Annual Meeting
May 28, 2024 06:59 ET
|
Pasithea
Pasithea to present preclinical data at ASCO 2024 showing PAS-004 superior inhibition of NRAS cancer cells and xenograft tumors compared to current MEKi's
Media Alert: Innovative Business Opportunities in Neurofibromatosis
June 09, 2014 10:19 ET
|
Children's Tumor Foundation
NEW YORK, N.Y., June 9, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) is hosting the 2014 NF Conference, the largest worldwide meeting dedicated entirely to neurofibromatosis (NF), a...
KEY MEDIA OPPORTUNITIES AT THE 2014 NF FORUM/CONFERENCE
June 06, 2014 16:54 ET
|
Children's Tumor Foundation
-- NIH Director Francis Collins to Deliver Keynote Address
-- First-ever 'Business Opportunities in NF' Satellite Meeting
NEW YORK, June 6, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor...
World's Largest Neurofibromatosis Conference to be Held in Washington, D.C.
June 03, 2014 16:52 ET
|
Children's Tumor Foundation
NEW YORK, June 3, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) is hosting the 2014 NF Conference/Forum, the largest worldwide meeting dedicated entirely to neurofibromatosis (NF), a...
Alzheimer's Drug Discovery Foundation and Children's Tumor Foundation announce Partnership to Provide Drug Discovery Resources for Research Community
March 14, 2014 10:31 ET
|
Children's Tumor Foundation
NEW YORK, N.Y., March 14, 2014 (GLOBE NEWSWIRE) -- The Alzheimer's Drug Discovery Foundation (ADDF) and The Children's Tumor Foundation (CTF) today announced a partnership to provide CTF's scientific...
Children's Tumor Foundation Announces Historic New Initiative in Neurofibromatosis Research
March 10, 2014 11:33 ET
|
Children's Tumor Foundation
NEW YORK, March 10, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation, the leading non-governmental organization dedicated to neurofibromatosis (NF) research, announced today an important new...
Children's Tumor Foundation Announces Leadership Change
January 15, 2014 14:16 ET
|
Children's Tumor Foundation
NEW YORK, Jan. 15, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) announced today that Annette Bakker, Chief Scientific Officer of the Foundation has been elevated to President,...